期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肺结核治疗的新方向——抗结核药物的肺部递送 被引量：1

A new direction for tuberculosis treatment——the pulmonary delivery of anti-tuberculosis drugs
下载PDF
导出
摘要 本文结合肺部的解剖学和生理学特征以及肺结核的病理学特征重点阐释了抗结核药物肺部递送的优势和应关注的问题。通过近几年若干肺部递送抗结核药物的研究实例说明了肺结核治疗的这一新途径的可行性。 This review highlights the advantages of the pulmonary delivery of anti-TB agents and the associated concerns based on the understanding of the characteristics of both the anatomy and physiology of the lung and the TB pathology. The feasibility of this new drug delivery approach has been recently proven by some case-studies on the pulmonary delivery of anti-TB agents.
作者 谌茜
机构地区 四川护理职业学院
出处 《上海医药》 CAS 2016年第17期71-77,共7页 Shanghai Medical & Pharmaceutical Journal
关键词 肺结核 肺部递送 巨噬细胞靶向 空气动力学直径 tuberculosis pulmonary delivery macrophage targeting aerodynamic diameter
分类号 R943 [医药卫生—药剂学] R521 [医药卫生—内科学]
  • 相关文献

参考文献49

  • 1Patton JS. Mechanisms of macromolecule absorption by the lungs[J]. Adv Drug Deliver Rev, 1996, 19(1): 3-36.
  • 2Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs[J]. Nat Rev Drug Discov, 2007, 6(1): 67-74.
  • 3Courrier HM, Butz N, Vandamme TF. Pulmonary drug delivery systems: recent developments and prospects[J]. Crit Rev Ther Drug Carrier Syst, 2002, 19(4-5): 425-498.
  • 4Weber S, Zimmer A, Pardeike J. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art[J]. Eur J Pharm Biopharm, 2014, 86(1): 7-22.
  • 5Stone KC, Mercer RR, Gehr P, et al. Allometric relationships of cell numbers and size in the mammalian lung[J]. Am J Resp Cell Mol, 1992, 6(2): 235-243.
  • 6Bur M, Henning A, Hein S, et al. Inhalative nanomedicine- opportunities and challenges[J]. Inhal Toxicol, 2009, 21(S1): 137-143.
  • 7Telko M J, Hickey A J. Dry powder inhaler formulation[J]. Resp Care, 2005, 50(9): 1209-1227.
  • 8Byron PR. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation[J]. J Pharma Sci-US, 1986, 75(5): 433-438.
  • 9MSller W, H~iuBinger K, Winkler-Heil R, et al. Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects[J]. J Appl Physiol, 2004, 97(6): 2200- 2206.
  • 10Lippmann M, Yeates DB, Albert RE. Deposition, retention, and clearance of inhaled particles[J]. Br J Ind Med, 1980, 37(4): 337-362.

同被引文献8

引证文献1

上海医药
2016年 第17期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部